134 related articles for article (PubMed ID: 19227203)
1. Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy.
Asha W; Obi E; Tendulkar R
Adv Radiat Oncol; 2023; 8(6):101288. PubMed ID: 38047224
[No Abstract] [Full Text] [Related]
2. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
Zincke H; Lau W; Bergstralh E; Blute ML
J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
[TBL] [Abstract][Full Text] [Related]
3. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
Fair WR; Betancourt JE
Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
[TBL] [Abstract][Full Text] [Related]
4. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
5. [Treatment results of radical prostatectomy in clinical stage B and C prostate cancer: comparison of the neoadjuvant therapy group versus the surgery group; retrospective analysis of 80 cases].
Ogura Y; Sakata Y; Wakita T; Hayashi N; Hioki T; Sugimura Y
Hinyokika Kiyo; 2003 Sep; 49(9):515-20. PubMed ID: 14598688
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of prostate specific antigen failure after radical prostatectomy for prostate cancer: a single center experience].
Taue R; Takahashi M; Fukawa T; Koizumi T; Nakanishi R; Yamaguchi K; Yamamoto Y; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Fukumori T; Kanayama HO
Hinyokika Kiyo; 2009 Jan; 55(1):1-4. PubMed ID: 19227203
[TBL] [Abstract][Full Text] [Related]
8. [Salvage radiotherapy for pT3 prostate cancer with PSA failure after radical prostatectomy].
Wakita T; Hayashi N; Fuwa N
Hinyokika Kiyo; 2005 Sep; 51(9):575-80. PubMed ID: 16229369
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic strategy for prostate specific antigen (PSA) failure after radical prostatectomy].
Kinoshita H; Kamoto T; Mitsumori M; Kiyokawa T; Habuchi T; Kakehi Y; Hiraoka M; Ogawa O
Gan To Kagaku Ryoho; 2003 Jan; 30(1):32-7. PubMed ID: 12557702
[TBL] [Abstract][Full Text] [Related]
10. Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy.
Lee AK; D'Amico AV
J Clin Oncol; 2005 Nov; 23(32):8192-7. PubMed ID: 16278472
[TBL] [Abstract][Full Text] [Related]
11. [Histopathological characteristics of radical prostatectomy specimen and long-term PSA changes in men with PSA levels of 4.0 ng/ml or less].
Kanno H; Umemoto S; Izumi K; Hasumi H; Osada Y; Ohta J; Tuchiya F; Kuwao S
Hinyokika Kiyo; 2008 Mar; 54(3):207-15. PubMed ID: 18411777
[TBL] [Abstract][Full Text] [Related]
12. [LHRH analogues for the treatment of prostate cancer: an evidence level-based analysis].
Pfitzenmaier J; Altwein JE
Aktuelle Urol; 2009 Mar; 40(2):100-8. PubMed ID: 19253209
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
